BioSpace News Archive

SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, today announced publication of 12-month follow up results of its SPRINT® Peripheral Nerve Stimulation (PNS) System used for the treatment of post-amputation pain.

The Implementation, Delivered On-Time via ArisGlobal’s Services Team, Enables the Top 5 Pharma to Process 1 Million Adverse Event Cases Annually

Developed from being a university spin-off to become a medium-sized company with renowned customers from all over the world

Innovent Biologics, Inc. announced that the latest clinical data of Fully-human BCMA CAR-T, a potential best-in-class cell therapy co-developed with IASO Biotherapeutics, has been presented in an oral session at the prestigious 61st Annual American Society of Hematology Meeting & Exposition convened in Orlando, FL, from 7 December 2019 to 10 December 2019.

ImmunOs Therapeutics AG, a Swiss bio-technology company and leading developer of a next generation innate immunity focused immunotherapy platform for cancer, announced the closing of a Series A financing of CHF 15 million.

Octapharma has announced that the final results from the NuProtect study, the largest prospective study of a single factor VIII product in true PUPs with severe haemophilia A, were presented in an oral presentation at the American Society of Hematology 2019 Annual Meeting in Orlando, Florida.

Investment will be used to scale the company’s patient management platform and enhance care delivery worldwide

Emergex Vaccines Holding Limited, a biotechnology company developing population-based synthetic disease prophylaxis ‘set-point’ vaccines in the field of infectious diseases, announced the successful completion of preclinical testing of its lead vaccine candidate for Dengue Fever.

Algernon Pharmaceuticals Inc., a clinical stage pharmaceutical development company, is pleased to announce that it will present at the 12th Annual LD Micro Main Event Conference to be held at the Luxe Sunset Hotel in Los Angeles, CA on December 11th at 2:20 PM Pacific Standard Time.

Virtually Painless TAP® Device Has Potential to Revolutionize Routine Blood Collection for Wellness Testing -